Home › Clear-cell metastatic renal cell carcinoma › New Jersey
Clear-cell metastatic renal cell carcinoma clinical trials in New Jersey
3 studies for Clear-cell metastatic renal cell carcinoma are looking for participants at sites in New Jersey.
Study of Casdatifan and Cabozantinib Versus Placebo and Cabozantinib in Patients With Advanced Clear Cell Renal Cell Carcinoma
- Research Site, New Brunswick
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 29, 2026 · NCT07011719Symbiotic-GU-08: A Study to Learn About the Medicine Called PF-08634404 Dosed Alone and in Combination With Other Anticancer Therapies in Adults With Locally Advanced or Metastatic Renal Cell Cancer
- MSK Basking Ridge, Basking Ridge
- MSK Monmouth, Middletown
- MSK Bergen, Montvale
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07227415Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
- Hackensack University Medical Center, Hackensack
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 9, 2025 · NCT04510597From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.